Two Assays to Evaluate Potential Genotoxic Effects of Hydroxyurea in Sickle Cell Disease Patients

REFERENCES

• Gwilt PR, Tracewell WG. Pharmacokinetics and pharmacodynamics of hydroxyurea. Clin Pharmacokinet. 1998;34(5):347–358.
   PubMed Web of Science ®Google Scholar
• Steven MR. Hydroxyurea: an overview. J Biol Regul Homeost Agents. 1999;13(3):172–175.
   PubMed Web of Science ®Google Scholar
• Ballas SK, Barton FB, Waclawiw MA, . Hydroxyurea and sickle cell anemia: effect on quality of life. Health Qual Life Outcomes. 2006;4(4):59.
   PubMedGoogle Scholar
• De Montalembert M. Traitement des patients drépanocytaires par hydroxyurée: efficacité et tolérance. Transfus Clin Biol. 2008;15(1–2):34–38.
   PubMedGoogle Scholar
• Gulbis B, Haberman D, Dufour D, . Hydroxyurea for sickle cells disease in children and for prevention of cerebrovascular events: the Belgian experience. Blood. 2005;105(7):2685–2690.
   PubMed Web of Science ®Google Scholar
• Mellouli F, Bejaouli M. L’utilisation de l’hydroxyurée dans les formes sévères de la drépanocytose: étude de 47 cas pédiatriques tunisiens. Arch Pediatr. 2008;15(1):24–28.
   PubMed Web of Science ®Google Scholar
• Moore RD, Charache S, Terrin ML, Barton FB, Ballas SK. Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. Am J Hematol 2000;64(1):26–31.
   Google Scholar
• Ballas SK. Sickle cell anaemia, progress in pathogenesis and treatment. Drugs. 2002;62(8):1143–1172.
   PubMed Web of Science ®Google Scholar
• Labie D, Elion J. Bases moléculaires et physiopathologiques des maladies de l’hémoglobine. EMC-Hématologie. 2005;2(4):220–239.
   Google Scholar
• Charache S, Dover GJ, Moore RD, . Hydroxyurea: effects on Hemoglobin F production in patients with sickle cell anemia. Blood. 1992;79(10):2555–2565.
   PubMed Web of Science ®Google Scholar
• McGann PT, Ware RE. Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? Curr Opin Hematol. 2011;18(3):158–165.
   PubMed Web of Science ®Google Scholar
• Schultz WH. Malignancy in patients with sickle cell disease. Am J Hematol. 2003;74(4):249–253.
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175(1):184–191.
   PubMed Web of Science ®Google Scholar
• Fairbairn DW, Olive PL, O’Neill KL. The comet assay: a comprehensive review. Mutat Res. 1995;339(1):37–59.
   PubMed Web of Science ®Google Scholar
• Olive PL. DNA damage and repair in individual cells: applications of the comet assay in radiobiology. Int J Radiat Biol. 1999;75(4):395–405.
   PubMed Web of Science ®Google Scholar
• Rojas E, Lopez MC, Valverde M. Single cell gel electrophoresis assay: methodology and applications. J Chromatogr B Biomed Sci Appl. 1999;722(1–2):225–254.
   PubMed Web of Science ®Google Scholar
• Tice RR, Agurell E, Anderson D, Burlinson B. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000;35(3):206–221.
   PubMed Web of Science ®Google Scholar
• Anderson D, Yu TW, Phillips BJ, Schmezer P. The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay. Mutat Res. 1994;307(1):261–271.
   PubMed Web of Science ®Google Scholar
• Gedik CM, Ewen SW, Collins AR. Single-cell gel electrophoresis applied to the analysis of UV-C damage and its repair in human cells. Int J Radiat Biol. 1992;62(3):313–320.
   PubMed Web of Science ®Google Scholar
• Bocker W, Bauch T, Muller WU, Streffer C. Image analysis of comet assay measurements. Int J Radiat Biol. 1997;72(4):449–460.
   PubMed Web of Science ®Google Scholar
• Kent CR, Eady JJ, Ross GM, Steel GG. The comet moment as a measure of DNA damage in the comet assay. Int J Radiat Biol. 1995;67(6):655–660.
   PubMed Web of Science ®Google Scholar
• Olive PL, Banath JP, Durand RE. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the “comet” assay. Radiat Res. 1990;122(1):86–94.
   PubMed Web of Science ®Google Scholar
• Collins AR. Investigating oxidative DNA damage and its repair using the comet assay. Mutat Res. 2009;681(1):24–32.
   PubMed Web of Science ®Google Scholar
• Dusinska M, Collins AR. The comet assay in human biomonitoring: gene-environment interactions. Mutagenesis. 2008;23(3):191–205.
   PubMed Web of Science ®Google Scholar
• Moller P, Friis G, Christensen PH, . Intra-laboratory comet assay sample scoring exercise for determination of formamidopyrimidine DNA glycosylase sites in human mononuclear blood cell DNA. Free Radic Res. 2004;38(11):1207–1214.
   PubMed Web of Science ®Google Scholar
• Cooke MS, Lunec J, Evans MD. Progress in the analysis of urinary oxidative DNA damage. Free Radic Biol Med. 2002;33(12):1601–1614.
   PubMed Web of Science ®Google Scholar
• Klaude M, Eriksson S, Nygren J, Ahnstrom G. The comet assay: mechanisms and technical considerations. Mutat Res.1996;363(2):89–96.
   PubMedGoogle Scholar
• Yarbro JW. Mechanism of action of hydroxyurea. Semin Oncol. 1992;19(3 Suppl 9):1–10.
   PubMed Web of Science ®Google Scholar
• Friedrish JR, Pra D, Maluf SW, . DNA damage in blood leukocytes of individuals with sickle cell disease treated with hydroxyurea. Mutat Res. 2008;649(1–2):213–220.
   PubMed Web of Science ®Google Scholar
• Khayat AS, Guimarães AC, Cardoso PCS, . Mutagenicity of hydroxyurea in lymphocytes from patients with sickle cell disease. Genet Mol Biol. 2004;27(1):115–117.
   Web of Science ®Google Scholar
• Khayat AS, Antunes LM, Guimarães AC, . Cytotoxic and genotoxic monitoring of sickle cell anaemia patients treated with hydroxyurea. Clin Exp Med. 2006;6(1):33–37.
   PubMed Web of Science ®Google Scholar
• Hebbel RP, Eaton JW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest. 1982;70(6):1253–1259.
   PubMed Web of Science ®Google Scholar
• Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982;47(5):412–426.
   PubMed Web of Science ®Google Scholar
• Aslan M, Thornley-Brown D, Freeman BA. Reactive species in sickle cell disease. Ann NY Acad Sci. 2000;899:375–391.
   PubMed Web of Science ®Google Scholar
• Yoshida R, Ogawa Y, Kasai H. Urinary 8-oxo-7,8-dihydro-2’-deoxyguanosine values measured by an ELISA correlated well with measurements by high-performance liquid chromatography with electrochemical detection. Cancer Epidemiol Biomarkers Prev. 2002;11(10 Pt 1):1076–1081.
   PubMed Web of Science ®Google Scholar